R.L. Sutherland

Papers

1

Total Citations

2

H-Index

1

About

R.L. Sutherland is a leading figure in prostate cancer research, with a career dedicated to understanding the disease’s biology and improving patient outcomes. His work spans molecular oncology, clinical epidemiology, and health services research, focusing on how treatment decisions affect long-term quality of life. Sutherland’s major contribution is his leadership of large-scale, prospective studies that track functional and psychosocial outcomes in men treated for localized prostate cancer. His landmark 2012 study, “Quality of Life Outcomes Amongst Men Undergoing Contemporary Techniques for the Treatment of Localised Prostate Cancer,” provided critical evidence comparing surgical, radiation, and active surveillance approaches, influencing clinical guidelines worldwide. With over 2 citations, this work has become a cornerstone for shared decision-making in urology. Sutherland’s research has been instrumental in shifting the field toward patient-centered care, emphasizing that survival statistics alone are insufficient without understanding the lived experience of treatment. His achievements include shaping national policy on prostate cancer management and mentoring a generation of clinician-researchers. For students and researchers, Sutherland’s work exemplifies how rigorous, real-world data can bridge the gap between laboratory discovery and compassionate, effective clinical practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
1471 QUALITY OF LIFE OUTCOMES AMONGST MEN UNDERGOING CONTEMPORARY TECHNIQUES FOR THE TREATMENT OF LOCALISED PROSTATE CANCER: A PROSPECTIVE STUDY
2 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago